There is evidence for reciprocal interactions between the brain monoamine neurotransmitters serotonin and noradrenaline which may play a critical role in homeostasis. The aim of the present study was to establish the effect of drug-induced damage to the serotoninergic system on noradrenergic activity in the hypothalamus. Bilateral intracerebroventricular injections of p-chlorophenylalanine (PCPA; 3 mg/kg in 2 × 6 μl) were made to induce destruction in the serotoninergic system. Relative to saline-injected controls, PCPA-injected rats began overeating by 3 days postinjection. On day 10, when the experimental rats were consuming approximately 120% that of controls, animals were 4-h food deprived, sacrificed and the medial basal hypothalamus was removed for later analysis (by gas chromatography/mass spectrometry) of noradrenaline (NA), serotonin (5-HT) and dopamine (DA) and their principal metabolites dihydroxyphenylethyleneglycol (DHPG), 5-hydroxyindoleacetic acid (5-IAAA) and 3,4-dihydroxyphenylacetic acid (DOPAC), respectively. The ratio of metabolite to monoamine provided an index of functional activity. Trunk blood was collected for analysis of serum insulin and glucose. PCPA-injected animals had higher levels of DHPG ( P < 0.05), an increase in the DHPG/NA ratio ( P <0.02), lower serum insulin ( P < 0.05) and increased serum glucose ( P < 0.05). There were significant correlations between noradrenergic activity (DHPG/NA ratio) and: (1) food intake (day 9 and 10 average; r = 0.62, P < 0.05); and (2) serum glucose ( r = 0.59, P < 0.05). In contrast, PCPA treatment only marginally lowered levels of 5-HT and 5-HIAA with no change in the 5-HIAA/5-HT ratio and no changes in DA or DOPAC or the DOPAC/DA ratio. Neither serotoninergic nor dopaminergic activity was related to any of the intake, body weight, insulin or glucose measures. We conclude that intracerebroventricular PCPA chronically elevates hypothalamic noradrenergic activity and this, rather than decreased serotoninergic activity, may lead to the observed hyperphagia, hyperglycemia and hypoinsulinemia.
Read full abstract